Comparing a head‐mounted virtual reality perimeter and the Humphrey Field Analyzer for visual field testing in healthy and glaucoma patients
Ophthalmic and Physiological Optics · 2024-01 · 44 (1) · 83-95
DOI: 10.1111/opo.13229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 06.10.2023. Verfasst von Jack Phu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry and Vision Science, University of New South Wales Sydney, Kensington, New South Wales, Australia. Hauptthemen laut MEDLINE: Glaucoma, Virtual Reality. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Purpose
To compare clinical visual field outputs in glaucoma and healthy patients returned by the Humphrey Field Analyzer (HFA) and virtual reality (Virtual Field, VF) perimetry.
Methods
One eye of 54 glaucoma patients and 41 healthy subjects was prospectively tested (three times each in random order) using the HFA and VF perimeters (24‐2 test grids). We extracted and compared global indices (mean deviation [MD] and pattern standard deviation [PSD]), pointwise sensitivity (and calculated ‘equivalent’ sensitivity after accounting for differences in background luminance) and pointwise defects. Bland–Altman (mean difference [ M diff ] and 95% limits of agreement [LoA]) and intraclass correlation analyses were performed.
Results
The VF test was shorter (by 76 s) and had lower fixation losses (by 0.08) and false‐positive rate (by 0.01) compared to the HFA (all p < 0.0001). Intraclass correlations were 0.86, 0.82 and 0.47 for MD, PSD and pointwise sensitivity between devices, respectively. Test–retest variability was higher for VF ( M diff 0.3 dB, LoA −7.6 to 8.2 dB) compared to the HFA ( M diff −0.3 dB, LoA −6.4 to 5.9 dB), indicating greater test–retest variability. When using each device's underlying normative database, the HFA detected, on average, 7 more defects (at the p < 0.05 level) out of the 52 test locations compared to this iteration of VF in the glaucoma cohort.
Conclusions
Virtual Field returns global results that are correlated with the HFA, but pointwise sensitivities were more variable. Differences in test–retest variability and defect detection by its current normative database raise questions about the widespread adoption of VF in lieu of the HFA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Optometry and Vision Science, University of New South Wales Sydney, Kensington, New South Wales, Australia.
- Centre for Eye Health, University of New South Wales Sydney, Kensington, New South Wales, Australia.
- Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
- Concord Clinical School, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
- School of Medicine (Optometry), Deakin University, Waurn Ponds, Victoria, Australia.
ORCID-Profile: Jack Phu, Michael Kalloniatis
Förderung
- National Health and Medical Research Council
Zitieren
APA
Phu, J., Wang, H., & Kalloniatis, M. (2024). Comparing a head‐mounted virtual reality perimeter and the Humphrey Field Analyzer for visual field testing in healthy and glaucoma patients. Ophthalmic and Physiological Optics, 44(1), 83-95. https://doi.org/10.1111/opo.13229
Vancouver
Phu J, Wang H, Kalloniatis M. Comparing a head‐mounted virtual reality perimeter and the Humphrey Field Analyzer for visual field testing in healthy and glaucoma patients. Ophthalmic and Physiological Optics. 2024;44(1):83-95. doi:10.1111/opo.13229
BibTeX
@article{Phu2024,
author = {Phu, Jack and Wang, Henrietta and Kalloniatis, Michael},
title = {Comparing a head‐mounted virtual reality perimeter and the Humphrey Field Analyzer for visual field testing in healthy and glaucoma patients},
journal = {Ophthalmic and Physiological Optics},
year = {2024},
volume = {44},
number = {1},
pages = {83--95},
doi = {10.1111/opo.13229}
}
EUVIMED